HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
INSM
Insmed Inc
Healthcare Biotechnology · New Jersey, USA · Reports in usd
Market Cap: $21.85B
Market Cap
$21.85B
Enterprise Val
$21.37B
P/E Ratio
-18.45
P/B Ratio
30.99
Trailing PEG (1Y)
0.40
As Of
May 7, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$704.9M
Gross Margin84.50%
Profit Margin84.50%
Return on Equity-130.11%
Return on Assets-51.57%
Current Ratio4.47
Debt/Equity1.05
LT Debt/Equity1.04
Revenue Per Share1.42

Income Statement

Mar 31, 2026
Revenue$306.0M
Cost of Revenue$47.4M
Gross Profit$258.5M
R&D$209.5M
SG&A$247.3M
Operating Expenses$458.8M
Operating Income-$200.3M
Interest Expense$20.1M
Tax Expense$1.5M
Net Income-$163.6M
EPS (Basic)$-0.76
EPS (Diluted)$-0.76
EBIT-$142.0M
EBITDA-$136.4M
Consolidated Income-$163.6M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$582.2M
Accounts Receivable$178.6M
Inventory$132.9M
Current Assets$1.61B
LT Investments$0.00
Property, Plant & Equipment$131.7M
Intangibles$231.7M
Non-Current Assets$462.7M
Total Assets$2.08B
Accounts Payable$352.6M
Current Debt$8.5M
Current Liabilities$361.0M
LT Debt$734.0M
Non-Current Liabilities$1.01B
Total Liabilities$1.37B
Total Debt$742.5M
Retained Earnings-$5.80B
Shareholder Equity$704.9M
Shares Outstanding215,551,896

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow-$222.7M
Investing Cash Flow$265.5M
Financing Cash Flow$29.5M
CapEx-$3.5M
Free Cash Flow-$226.2M
Depreciation & Amort.$5.6M
Stock-Based Comp$45.8M
Acquisitions / Disposals-$15.0M
Investment Activity$284.0M
Debt Issued/Repaid-$799.0K
Equity Issued/Repaid$30.3M
Dividends Paid$0.00
Net Change in Cash$71.7M
Data cached · Meta live · Daily live · Statements live · TTL 24h